569655-94-3 Usage
Chemical structure
The compound consists of a triazine ring fused with an indole ring and a phenyl group attached to the 6th position.
Heterocyclic compound
It is a complex organic compound containing both triazine and indole heterocyclic rings.
Potential pharmacological and biological activities
Due to the presence of the indole and triazine rings, the compound may exhibit various biological activities, making it a candidate for pharmaceutical research.
Indole ring
A common structural motif found in many natural and synthetic compounds with diverse biological activities.
Triazine ring
Present in various pharmaceuticals and agrochemicals, contributing to the compound's potential applications.
Unique structure and properties
The fusion of the triazine and indole rings, along with the phenyl group, gives the compound its unique structure and properties.
Potential applications
The compound may have applications in medicine and the development of new materials with specific properties due to its unique structure.
Molecular weight
The molecular weight of the compound can be calculated based on its chemical formula and the atomic weights of its constituent elements.
Stability
The stability of the compound under different conditions (e.g., temperature, pH, light exposure) can be crucial for its shelf life and potential use in various applications.
Synthesis
The synthesis of the compound may involve multiple steps, including the formation of the triazine and indole rings, followed by their fusion and attachment of the phenyl group.
Analytical techniques
Various analytical techniques, such as NMR, mass spectrometry, and X-ray crystallography, can be used to characterize and confirm the structure of the compound.
Biological assays
In vitro and in vivo assays can be performed to evaluate the compound's pharmacological and biological activities, such as its potential as a drug candidate or its effects on specific biological targets.
Toxicity
The compound's toxicity profile should be assessed to determine its safety for potential pharmaceutical applications or other uses.
Check Digit Verification of cas no
The CAS Registry Mumber 569655-94-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,6,9,6,5 and 5 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 569655-94:
(8*5)+(7*6)+(6*9)+(5*6)+(4*5)+(3*5)+(2*9)+(1*4)=223
223 % 10 = 3
So 569655-94-3 is a valid CAS Registry Number.
569655-94-3Relevant academic research and scientific papers
Addition of C-nucleophiles to 5-phenylpyrimidin-2(1H)-ones and 6-phenyl-1,2,4-triazin-3(2H)-one
Egorov, Ilya N.,Tseitler, Tatyana A.,Zyryanov, Grigory V.,Rusinov, Vladimir L.,Chupakhin, Oleg N.
experimental part, p. 312 - 323 (2011/12/15)
Addition reactions of C-nucleophiles to the C=N bond of 5-phenyl- and 1-methyl-5-phenylpyrimidin-2(1H)-ones 1a,b and 6-phenyl-1,2,4-triazin-3(2H)-one 2 were investigated. 1a,b and 2 furnished addition products with indoles; 1a also added N-methylpyrrole. Only 2 added thiophene and methyl ketones, and reacted with alkyl halides and acetone forming products resulting both from alkylation and from addition of acetone at positions 2 and 5, respectively.
Asymmetric induction in the reactions of azinones with C-nucleophiles
Chupakhin,Egorov,Rusinov,Slepukhin
experimental part, p. 991 - 1001 (2011/02/27)
Effect of acylating agents on the course of addition of C-nucleophiles to 1,2,4- and 1,3,5-triazinones, as well as to quinoxalin-2(1H)-one, was studied. A series of new azinone derivatives was obtained. A method for the preparation of diastereomerically pure addition products of indoles to 1,2,4-triazinones and quinoxalin-2(1H)-one in the presence of N-Ts-L-amino acid acyl chlorides was suggested.
Methods of treating conditions associated with an EDG-4 receptor
-
, (2008/06/13)
The present invention provides a method of modulating an Edg-4 receptor mediated biological activity in a cell. A cell expressing the Edg-4 receptor is contacted with a modulator of an Edg-4 receptor sufficient to modulate the Edg-4 receptor mediated biol
